1 Stock This Technical Trader Says Could Surge Nearly 14% Higher In the Near-Term

And analysts say the stock could go far higher than that. Here’s why. 

As the U.S. and China get closer to signing a phase one trade deal, Chinese stocks are starting to break out. 

Over the last week, the iShares China Large Cap ETF is up 3.29%, and MKM Partners chief market technician, J.C. O’Hara, says one stock in the ETF could soon surge far higher.

“The charts have definitely seen some notable recent strength, but I don’t know if they’re just out of the woods yet,” O’Hara told CNBC. 

But for Alibaba (NYSE: BABA), O’Hara says the stock could climb more than 14% in the near term.

“If you go back over the last 12 to 18 months, you do see a series of higher lows in place, and that’s definitely positive, but there’s still a series of lower highs,” O’Hara said. O’Hara continued that he remained “cautious” on the stock until it broke above $185, and on Thursday, it did just that.

“We get positive above that $185 level because above $185, we think there’s a clear shot to the 2018 highs at $210,” O’Hara said. “So that’s why i turned incrementally more positive.”

Alibaba’s record high last year was $211, or 13.9% higher than the current price. And analysts say it could climb even higher. 

The consensus price target on BABA is $225.87—21% higher than the current price—with Benchmark analyst Fawne Jiang calling Alibaba the Chinese “e-commerce category killer” late last week.

Tocqueville Asset Management’s John Petrides says Chinese stocks as a whole are starting to look better.

“We think the large-cap tech social media giants in China are quite attractive particularly over the long term,” Petrides said. “They generate a ton of cash flow, the demographics are in favor and… in September, the risk was that the U.S. may delist Chinese securities. That does seem to be behind us, which I think provides a valuation opportunity.”

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More